Human Milk Oligosaccharides (HMO) Market - Forecast(2021 - 2026)

Report Code: FBR 0264 Report Format: PDF + Excel (Delivery in 48 Hrs)

Human Milk Oligosaccharides (HMO) Market Overview 

Human Milk Oligosaccharides (HMO) Market size was valued at $ 64.17 Million by 2019, and is anticipated to grow at a CAGR of 5.8% during the forecast period 2020-2025. The Human Milk Oligosaccharides (HMO) Market growth rate is attributed to the growing concerns among consumers regarding gut health and the growing consumption of dietary supplements is anticipated to bring new opportunities. Human Milk Oligosaccharides (HMOs) act as prebiotics in the human body and help maintain gut health. They promote bacterial growth, especially bifidobacteria genus, in the gut, which helps improve metabolic activity. The antimicrobial protection and prebiotic functions of the product allow them to be used in various food products, including pharmaceutical and medicinal food and infant formulas. Apart from this, incorporation of human milk oligosaccharides in functional food and beverages promotes the growth of good bacteria and eliminates harmful bacteria, including salmonella, listeria, and campylobacter. Dairy products dominate the functional food market. There is a high demand for functional food and beverages with prebiotic properties. Lack of technology for large-scale production, high R&D cost, and stringent government regulations are likely to restrain the HMO market growth. Infant formula is the largest application segment for the product, which promote health and prevent diseases in infants. Moreover, these play a vital role in brain development and memory enhancement in humans.

Human Milk Oligosaccharides (HMO) Market Report Coverage

The report: “Human Milk Oligosaccharides (HMO) Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Human Milk Oligosaccharides (HMO) Market:
By Product: Lacto-N-neotetraose (LNnT), Lacto-N-tetraose (LNT), 2'-Fucosyllactose (2'FL), 3'-Fucosyllactose (3'FL), 3'-Sialyllactose (3'SL), 6'-Sialyllactose (6'SL) and others.
By Type: Neutral, Acidic and Others.
By Applications: Food & beverages, Food supplements, Infant formulas and others.
By Geography: North America, Europe, Asia-Pacific and RoW.

Key Takeaways

  • Europe dominated the Human Milk Oligosaccharides (HMO) Market with a share of 42.16% in the year 2019.
  • The factors such as growing concerns among consumers regarding gut health and the growing consumption of dietary supplements are amongst the major factor projected to impel growth of Human Milk Oligosaccharides (HMO) Market.
  • Rising demand for infant formula, promising growth of the dairy industry and the consciousness in health are the key factors owing to the growth in the segment during forecast period 2020-2025.

Human Milk Oligosaccharides (HMO) Market Segment Analysis - By Product

On the basis of product, Lacto-N-neotetraose segment accounted for major share in 2019. This is owing to increasing growth of beneficial bifidobacteria and decreasing the growth of pathogenic bacteria which is eventually attracting the manufacturers of food and beverages and food supplements owing to the growing health consciousness among the customers, which is estimated to enhance the growth of the human milk oligosaccharides (HMO) market. However, 2'-Fucosyllactose (2'FL) segment is set to be fastest growing during the forecast period 2020-2025 with a CAGR of 6.2%. Manufacturers of dietary supplements are shifting towards 2’-fucosyllactose (2’FL) owing to its capability of altering the composition and activity of gut microbiota from formula-fed infants receiving complementary feeding and its contribution in the development of healthy gut, which is estimated to propel the growth of the human milk oligosaccharides (HMO) market.

Human Milk Oligosaccharides (HMO) Market Segment Analysis - By Applications

Based on applications, Infant Formulas application accounted for major share in 2019. This can be attributed to the fact that the increasing number of middle-class households and the number of working women are the major factors increasing the demand of human milk oligosaccharides (HMOs) in infant formulas. Furthermore, the demand of human milk oligosaccharides (HMOs) in infant formulas is increasing as it promotes the infant health by supporting digestive, immune, and cognitive development, which is said to enhance the growth of the human milk oligosaccharides (HMO) market. 

Human Milk Oligosaccharides (HMO) Market Segment Analysis - By Geography

Europe is the major region dominating the Human Milk Oligosaccharides Market with revenue share of 42.12% in 2019. This is owing to presence of numerous prominent infant formula and baby food manufacturers along with technological advancement.
However, Asia Pacific region is projected to be the fastest growing region with fastest CAGR during the forecast period 2020-2025. This is owing to rising population, mortality rate, disposable income, and consumer awareness regarding health and hygiene. Rising concerns regarding gut diseases, high blood pressure, and diabetes.

Human Milk Oligosaccharides (HMO) Market Drivers

Rising Demand of HMO In Infant Formula

The Human Milk Oligosaccharides (HMO) market is poised to receive upswing owing to beneficial properties such as infection prevention, memory enhancement, brain growth, prebiotic effects, and improvement of intestinal health, the demand for HMOs in the design of infant formulas is growing. Moreover, the market for Human Milk Oligosaccharides (HMO) is poised to rise at a rapid pace during the forecast period 2020-2025 owing towards the rising health awareness rapidly among people in developing countries. In functional food and beverage products and food supplements, human milk oligosaccharides may help to treat certain diseases and high-risk health conditions, which is set to raise product demand.

Human Milk Oligosaccharides (HMO) Market Challenges

High Cost Of Product Owing To Expensive Manufacturing Process

Despite several drivers, owing to the low availability of a group of donors, HMO cannot be synthesized directly from human milk. At present, manufacturers are developing technologies through chemical and enzymatic synthesis to generate human milk oligosaccharides. These synthetic and enzymatic methods require a high amount of capital and energy, but the production of the final product is relatively low. For instance, for expensive substrates such as glycosyltransferases, enzymatic synthesis is necessary and this is one of the major factors attributed to the high price of oligosaccharides of human milk.

Human Milk Oligosaccharides (HMO) Industry Outlook

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Human Milk Oligosaccharides (HMO) Market. In 2019, Human Milk Oligosaccharides (HMO) Market share is fragmented by the top ten players present in the market. Human Milk Oligosaccharides (HMO) Market top 10 companies are Glycom A/S, Inbiose NV, Nestle Nutrition, Jennewein Biotechnologies GmbH, DuPont Nutrition, Medolac Laboratories, ZuChem Inc., Elicityl S.A., BASF SE, Glycosyn LLC and others.

Acquisitions/Product Launches

  • In September 2020, Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/Denmark, to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein Biotechnologie, the innovation and market leader in this high-growth market.
  • In October 2017, Abbott announced the launch in Mexico of its most recent innovative products in child nutrition, which contain HMOs, with the purpose of supporting immune and digestive health.

1. Human Milk Oligosaccharides (HMO) Market Overview
    1.1 Definitions and Scope
2. Human Milk Oligosaccharides (HMO) Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product
    2.3 Key trends by Applications
    2.4 Key trends by Geography
3. Human Milk Oligosaccharides (HMO) Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Patent Analysis – Key Companies
    3.4 Pricing Analysis
4. Human Milk Oligosaccharides (HMO) Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Human Milk Oligosaccharides (HMO) Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Human Milk Oligosaccharides (HMO) Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Human Milk Oligosaccharides (HMO) Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Human Milk Oligosaccharides (HMO) Market – By Product (Market Size – $Million/$Billion)
    8.1 Lacto-N-neotetraose (LNnT)
    8.2 Lacto-N-tetraose (LNT)
    8.3 2'-Fucosyllactose (2'FL)
    8.4 3'-Fucosyllactose (3'FL)
    8.5 3'-Sialyllactose (3'SL)
    8.6 6'-Sialyllactose (6'SL)
    8.7 Others 
9. Human Milk Oligosaccharides (HMO) Market - By Type (Market Size – $Million/$Billion)
    9.1 Neutral
    9.2 Acidic
    9.3 Others
10. Human Milk Oligosaccharides (HMO) Market - By Applications (Market Size – $Million/$Billion)
    10.1 Food & beverages
    10.2 Food supplements
    10.3 Infant formulas
    10.4 Others
11. Human Milk Oligosaccharides (HMO) Market - By Geography (Market Size – $Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 South America
        11.2.1 Brazil
        11.2.2 Venezuela
        11.2.3 Argentina
        11.2.4 Ecuador
        11.2.5 Peru
        11.2.6 Colombia
        11.2.7 Costa Rica
        11.2.8 Rest of South America
    11.3 Europe
        11.3.1 U.K.
        11.3.2 Germany
        11.3.3 France
        11.3.4 Italy
        11.3.5 Netherlands
        11.3.6 Belgium
        11.3.7 Spain
        11.3.8 Denmark
        11.3.9 Rest of Europe
    11.4 Asia-Pacific
        11.4.1 China
        11.4.2 India
        11.4.3 Japan
        11.4.4 South Korea
        11.4.5 Australia & New Zealand
        11.4.6 Taiwan
        11.4.7 Malaysia
        11.4.8 Rest of Asia-Pacific
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Human Milk Oligosaccharides (HMO) Market - Entropy
13. Human Milk Oligosaccharides (HMO) Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Human Milk Oligosaccharides (HMO) Market – Key Company List by Country Premium Premium
15. Human Milk Oligosaccharides (HMO) Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables
Table 1 Human Milk Oligosaccharides (HMO) Market Overview 2019-2024
Table 2 Human Milk Oligosaccharides (HMO) Market Leader Analysis 2018-2019 (US$)
Table 3 Human Milk Oligosaccharides (HMO) Market Product Analysis 2018-2019 (US$)
Table 4 Human Milk Oligosaccharides (HMO) Market End User Analysis 2018-2019 (US$)
Table 5 Human Milk Oligosaccharides (HMO) Market Patent Analysis 2013-2018* (US$)
Table 6 Human Milk Oligosaccharides (HMO) Market Financial Analysis 2018-2019 (US$)
Table 7 Human Milk Oligosaccharides (HMO) Market Driver Analysis 2018-2019 (US$)
Table 8 Human Milk Oligosaccharides (HMO) Market Challenges Analysis 2018-2019 (US$)
Table 9 Human Milk Oligosaccharides (HMO) Market Constraint Analysis 2018-2019 (US$)
Table 10 Human Milk Oligosaccharides (HMO) Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11 Human Milk Oligosaccharides (HMO) Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12 Human Milk Oligosaccharides (HMO) Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13 Human Milk Oligosaccharides (HMO) Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14 Human Milk Oligosaccharides (HMO) Market Degree of Competition Analysis 2018-2019 (US$)
Table 15 Human Milk Oligosaccharides (HMO) Market Value Chain Analysis 2018-2019 (US$)
Table 16 Human Milk Oligosaccharides (HMO) Market Pricing Analysis 2019-2024 (US$)
Table 17 Human Milk Oligosaccharides (HMO) Market Opportunities Analysis 2019-2024 (US$)
Table 18 Human Milk Oligosaccharides (HMO) Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19 Human Milk Oligosaccharides (HMO) Market Supplier Analysis 2018-2019 (US$)
Table 20 Human Milk Oligosaccharides (HMO) Market Distributor Analysis 2018-2019 (US$)
Table 21 Human Milk Oligosaccharides (HMO) Market Trend Analysis 2018-2019 (US$)
Table 22 Human Milk Oligosaccharides (HMO) Market Size 2018 (US$)
Table 23 Human Milk Oligosaccharides (HMO) Market Forecast Analysis 2019-2024 (US$)
Table 24 Human Milk Oligosaccharides (HMO) Market Sales Forecast Analysis 2019-2024 (Units)
Table 25 Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26 Human Milk Oligosaccharides (HMO) Market By Type, Revenue & Volume, By Introduction, 2019-2024 ($)
Table 27 Human Milk Oligosaccharides (HMO) Market By Type, Revenue & Volume, By Neutral, 2019-2024 ($)
Table 28 Human Milk Oligosaccharides (HMO) Market By Type, Revenue & Volume, By Acidic, 2019-2024 ($)
Table 29 Human Milk Oligosaccharides (HMO) Market By Type, Revenue & Volume, By Others, 2019-2024 ($)
Table 30 Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 31 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By Introduction, 2019-2024 ($)
Table 32 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By Lacto-N-neotetraose (LnnT), 2019-2024 ($)
Table 33 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By Lacto-N-tetraose (LNT), 2019-2024 ($)
Table 34 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By 2'-Fucosyllactose (2'FL), 2019-2024 ($)
Table 35 Human Milk Oligosaccharides (HMO) Market By Product, Revenue & Volume, By 3'-Fucosyllactose (3'FL), 2019-2024 ($)
Table 36 Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 37 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Introduction, 2019-2024 ($)
Table 38 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Food & beverages, 2019-2024 ($)
Table 39 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Food supplements, 2019-2024 ($)
Table 40 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Infant formulas, 2019-2024 ($)
Table 41 Human Milk Oligosaccharides (HMO) Market By Application, Revenue & Volume, By Others, 2019-2024 ($)
Table 42 North America Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 43 North America Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 44 North America Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 45 South america Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 46 South america Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 47 South america Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 48 Europe Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 49 Europe Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 50 Europe Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 51 APAC Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 52 APAC Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 53 APAC Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 54 Middle East & Africa Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 55 Middle East & Africa Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 56 Middle East & Africa Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 57 Russia Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 58 Russia Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 59 Russia Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 60 Israel Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 61 Israel Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 62 Israel Human Milk Oligosaccharides (HMO) Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 63 Top Companies 2018 (US$)Human Milk Oligosaccharides (HMO) Market, Revenue & Volume
Table 64 Product Launch 2018-2019Human Milk Oligosaccharides (HMO) Market, Revenue & Volume
Table 65 Mergers & Acquistions 2018-2019Human Milk Oligosaccharides (HMO) Market, Revenue & Volume

List of Figures
Figure 1 Overview of Human Milk Oligosaccharides (HMO) Market 2019-2024
Figure 2 Market Share Analysis for Human Milk Oligosaccharides (HMO) Market 2018 (US$)
Figure 3 Product Comparison in Human Milk Oligosaccharides (HMO) Market 2018-2019 (US$)
Figure 4 End User Profile for Human Milk Oligosaccharides (HMO) Market 2018-2019 (US$)
Figure 5 Patent Application and Grant in Human Milk Oligosaccharides (HMO) Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Human Milk Oligosaccharides (HMO) Market 2018-2019 (US$)
Figure 7 Market Entry Strategy in Human Milk Oligosaccharides (HMO) Market 2018-2019
Figure 8 Ecosystem Analysis in Human Milk Oligosaccharides (HMO) Market 2018
Figure 9 Average Selling Price in Human Milk Oligosaccharides (HMO) Market 2019-2024
Figure 10 Top Opportunites in Human Milk Oligosaccharides (HMO) Market 2018-2019
Figure 11 Market Life Cycle Analysis in Human Milk Oligosaccharides (HMO) Market
Figure 12 GlobalBy TypeHuman Milk Oligosaccharides (HMO) Market Revenue, 2019-2024 ($)
Figure 13 GlobalBy ProductHuman Milk Oligosaccharides (HMO) Market Revenue, 2019-2024 ($)
Figure 14 GlobalBy ApplicationHuman Milk Oligosaccharides (HMO) Market Revenue, 2019-2024 ($)
Figure 15 Global Human Milk Oligosaccharides (HMO) Market - By Geography
Figure 16 Global Human Milk Oligosaccharides (HMO) Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 17 Global Human Milk Oligosaccharides (HMO) Market CAGR, By Geography, 2019-2024 (%)
Figure 18 North America Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 19 US Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 20 US GDP and Population, 2018-2019 ($)
Figure 21 US GDP – Composition of 2018, By Sector of Origin
Figure 22 US Export and Import Value & Volume, 2018-2019 ($)
Figure 23 Canada Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 24 Canada GDP and Population, 2018-2019 ($)
Figure 25 Canada GDP – Composition of 2018, By Sector of Origin
Figure 26 Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 27 Mexico Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 28 Mexico GDP and Population, 2018-2019 ($)
Figure 29 Mexico GDP – Composition of 2018, By Sector of Origin
Figure 30 Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 31 South America Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 32 Brazil Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 33 Brazil GDP and Population, 2018-2019 ($)
Figure 34 Brazil GDP – Composition of 2018, By Sector of Origin
Figure 35 Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 36 Venezuela Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 37 Venezuela GDP and Population, 2018-2019 ($)
Figure 38 Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 39 Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 40 Argentina Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 41 Argentina GDP and Population, 2018-2019 ($)
Figure 42 Argentina GDP – Composition of 2018, By Sector of Origin
Figure 43 Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 44 Ecuador Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 45 Ecuador GDP and Population, 2018-2019 ($)
Figure 46 Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 47 Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 48 Peru Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 49 Peru GDP and Population, 2018-2019 ($)
Figure 50 Peru GDP – Composition of 2018, By Sector of Origin
Figure 51 Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 52 Colombia Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 53 Colombia GDP and Population, 2018-2019 ($)
Figure 54 Colombia GDP – Composition of 2018, By Sector of Origin
Figure 55 Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 56 Costa Rica Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 57 Costa Rica GDP and Population, 2018-2019 ($)
Figure 58 Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 59 Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 60 Europe Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 61 U.K Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 62 U.K GDP and Population, 2018-2019 ($)
Figure 63 U.K GDP – Composition of 2018, By Sector of Origin
Figure 64 U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 65 Germany Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 66 Germany GDP and Population, 2018-2019 ($)
Figure 67 Germany GDP – Composition of 2018, By Sector of Origin
Figure 68 Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 69 Italy Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 70 Italy GDP and Population, 2018-2019 ($)
Figure 71 Italy GDP – Composition of 2018, By Sector of Origin
Figure 72 Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 73 France Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 74 France GDP and Population, 2018-2019 ($)
Figure 75 France GDP – Composition of 2018, By Sector of Origin
Figure 76 France Export and Import Value & Volume, 2018-2019 ($)
Figure 77 Netherlands Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 78 Netherlands GDP and Population, 2018-2019 ($)
Figure 79 Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 80 Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 81 Belgium Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 82 Belgium GDP and Population, 2018-2019 ($)
Figure 83 Belgium GDP – Composition of 2018, By Sector of Origin
Figure 84 Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 85 Spain Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 86 Spain GDP and Population, 2018-2019 ($)
Figure 87 Spain GDP – Composition of 2018, By Sector of Origin
Figure 88 Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 89 Denmark Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 90 Denmark GDP and Population, 2018-2019 ($)
Figure 91 Denmark GDP – Composition of 2018, By Sector of Origin
Figure 92 Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 93 APAC Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 94 China Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024
Figure 95 China GDP and Population, 2018-2019 ($)
Figure 96 China GDP – Composition of 2018, By Sector of Origin
Figure 97 China Export and Import Value & Volume, 2018-2019 ($)Human Milk Oligosaccharides (HMO) Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 98 Australia Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 99 Australia GDP and Population, 2018-2019 ($)
Figure 100 Australia GDP – Composition of 2018, By Sector of Origin
Figure 101 Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 102 South Korea Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 103 South Korea GDP and Population, 2018-2019 ($)
Figure 104 South Korea GDP – Composition of 2018, By Sector of Origin
Figure 105 South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 106 India Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 107 India GDP and Population, 2018-2019 ($)
Figure 108 India GDP – Composition of 2018, By Sector of Origin
Figure 109 India Export and Import Value & Volume, 2018-2019 ($)
Figure 110 Taiwan Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 111 Taiwan GDP and Population, 2018-2019 ($)
Figure 112 Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 113 Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 114 Malaysia Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 115 Malaysia GDP and Population, 2018-2019 ($)
Figure 116 Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 117 Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 118 Hong Kong Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 119 Hong Kong GDP and Population, 2018-2019 ($)
Figure 120 Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 121 Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 122 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 123 Russia Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 124 Russia GDP and Population, 2018-2019 ($)
Figure 125 Russia GDP – Composition of 2018, By Sector of Origin
Figure 126 Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 127 Israel Human Milk Oligosaccharides (HMO) Market Value & Volume, 2019-2024 ($)
Figure 128 Israel GDP and Population, 2018-2019 ($)
Figure 129 Israel GDP – Composition of 2018, By Sector of Origin
Figure 130 Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 131 Entropy Share, By Strategies, 2018-2019* (%)Human Milk Oligosaccharides (HMO) Market
Figure 132 Developments, 2018-2019*Human Milk Oligosaccharides (HMO) Market
Figure 133 Company 1 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 134 Company 1 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135 Company 1 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 136 Company 2 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 137 Company 2 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138 Company 2 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 139 Company 3 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 140 Company 3 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141 Company 3 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 142 Company 4 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 143 Company 4 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144 Company 4 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 145 Company 5 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 146 Company 5 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147 Company 5 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 148 Company 6 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 149 Company 6 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150 Company 6 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 151 Company 7 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 152 Company 7 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153 Company 7 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 154 Company 8 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 155 Company 8 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156 Company 8 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 157 Company 9 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 158 Company 9 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159 Company 9 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 160 Company 10 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 161 Company 10 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162 Company 10 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 163 Company 11 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 164 Company 11 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165 Company 11 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 166 Company 12 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 167 Company 12 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168 Company 12 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 169 Company 13 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 170 Company 13 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171 Company 13 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 172 Company 14 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 173 Company 14 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174 Company 14 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)
Figure 175 Company 15 Human Milk Oligosaccharides (HMO) Market Net Revenue, By Years, 2018-2019* ($)
Figure 176 Company 15 Human Milk Oligosaccharides (HMO) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 177 Company 15 Human Milk Oligosaccharides (HMO) Market Net Sales Share, By Geography, 2018 (%)